Cargando…

Extrinsic Amyloid-Binding Dyes for Detection of Individual Protein Aggregates in Solution

[Image: see text] Protein aggregation is a key molecular feature underlying a wide array of neurodegenerative disorders, including Alzheimer’s and Parkinson’s diseases. To understand protein aggregation in molecular detail, it is crucial to be able to characterize the array of heterogeneous aggregat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taylor, Christopher G., Meisl, Georg, Horrocks, Mathew H., Zetterberg, Henrik, Knowles, Tuomas P. J., Klenerman, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2018
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127805/ https://www.ncbi.nlm.nih.gov/pubmed/30059210 http://dx.doi.org/10.1021/acs.analchem.8b02226

Ejemplares similares

Quantitative analysis of intrinsic and extrinsic factors in the aggregation mechanism of Alzheimer-associated Aβ-peptide
por: Meisl, Georg, et al.
Publicado: (2016)

An Environmentally Sensitive Fluorescent Dye as a Multidimensional Probe of Amyloid Formation
por: Yates, Emma V., et al.
Publicado: (2016)

Mechanistic Models of Protein Aggregation Across Length-Scales and Time-Scales: From the Test Tube to Neurodegenerative Disease
por: Meisl, Georg, et al.
Publicado: (2022)

Influence of denaturants on amyloid β42 aggregation kinetics
por: Weiffert, Tanja, et al.
Publicado: (2022)

Single-Molecule Imaging of Individual Amyloid Protein Aggregates in Human Biofluids
por: Horrocks, Mathew H., et al.
Publicado: (2016)

A mechanistic model of tau amyloid aggregation based on direct observation of oligomers
por: Shammas, Sarah L., et al.
Publicado: (2015)

Oligomer Diversity during the Aggregation of the Repeat Region of Tau
por: Kjaergaard, Magnus, et al.
Publicado: (2018)

Amyloids and protein aggregation
por: Linse, Sara, et al.
Publicado: (2023)

Absolute Quantification of Amyloid Propagons by Digital Microfluidics
por: Pfammatter, Manuela, et al.
Publicado: (2017)

Transthyretin Inhibits Primary and Secondary Nucleations of Amyloid-β Peptide Aggregation and Reduces the Toxicity of Its Oligomers
por: Ghadami, Seyyed Abolghasem, et al.
Publicado: (2020)

Uncovering the universality of self-replication in protein aggregation and its link to disease
por: Meisl, Georg, et al.
Publicado: (2022)

Modulation of electrostatic interactions to reveal a reaction network unifying the aggregation behaviour of the Aβ42 peptide and its variants
por: Meisl, Georg, et al.
Publicado: (2017)

Autocatalytic amplification of Alzheimer-associated Aβ42 peptide aggregation in human cerebrospinal fluid
por: Frankel, Rebecca, et al.
Publicado: (2019)

The catalytic nature of protein aggregation
por: Dear, Alexander J., et al.
Publicado: (2020)

The role of fibril structure and surface hydrophobicity in secondary nucleation of amyloid fibrils
por: Thacker, Dev, et al.
Publicado: (2020)

On the role of sidechain size and charge in the aggregation of Aβ42 with familial mutations
por: Yang, Xiaoting, et al.
Publicado: (2018)

Direct observation of prion protein oligomer formation reveals an aggregation mechanism with multiple conformationally distinct species
por: Sang, Jason C., et al.
Publicado: (2019)

Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation
por: Braun, Gabriel A., et al.
Publicado: (2022)

Identification of on- and off-pathway oligomers in amyloid fibril formation
por: Dear, Alexander J., et al.
Publicado: (2020)

β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces
por: Brown, James W. P., et al.
Publicado: (2016)

Kinetic analysis reveals that independent nucleation events determine the progression of polyglutamine aggregation in C. elegans
por: Sinnige, Tessa, et al.
Publicado: (2021)

Physical Determinants of Amyloid Assembly in Biofilm Formation
por: Andreasen, Maria, et al.
Publicado: (2019)

Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates
por: Scheidt, Tom, et al.
Publicado: (2019)

Characterization of full-length p53 aggregates and their kinetics of formation
por: Julian, Linda, et al.
Publicado: (2022)

Estimating Extrinsic Dyes for Fluorometric Online Monitoring of Antibody Aggregation in CHO Fed-Batch Cultivations
por: Schwab, Karen, et al.
Publicado: (2017)

Effects of sedimentation, microgravity, hydrodynamic mixing and air–water interface on α-synuclein amyloid formation
por: Zhou, Jiangtao, et al.
Publicado: (2020)

Mapping the binding site topology of amyloid protein aggregates using multivalent ligands
por: Sanna, Elena, et al.
Publicado: (2021)

Ultrastructural evidence for self-replication of Alzheimer-associated Aβ42 amyloid along the sides of fibrils
por: Törnquist, Mattias, et al.
Publicado: (2020)

Single-Molecule Measurements of Transient Biomolecular Complexes through Microfluidic Dilution
por: Horrocks, Mathew H., et al.
Publicado: (2013)

In situ kinetic measurements of α-synuclein aggregation reveal large population of short-lived oligomers
por: Zurlo, Enrico, et al.
Publicado: (2021)

Super-resolution imaging reveals α-synuclein seeded aggregation in SH-SY5Y cells
por: Sang, Jason C., et al.
Publicado: (2021)

Direct Observation of Murine Prion Protein Replication in Vitro
por: Sang, Jason C., et al.
Publicado: (2018)

Extrinsic Fluorescent Dyes as Tools for Protein Characterization
por: Hawe, Andrea, et al.
Publicado: (2008)

Imaging individual protein aggregates to follow aggregation and determine the role of aggregates in neurodegenerative disease
por: De, Suman, et al.
Publicado: (2019)

Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson’s disease genetically related mutants
por: Tosatto, Laura, et al.
Publicado: (2015)

Distinct thermodynamic signature of oligomer generation in the aggregation of the amyloid-β peptide
por: Cohen, Samuel I. A., et al.
Publicado: (2018)

Thioflavin T as an amyloid dye: fibril quantification, optimal concentration and effect on aggregation
por: Xue, Christine, et al.
Publicado: (2017)

Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer’s disease
por: Sideris, Dimitrios I, et al.
Publicado: (2021)

Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression
por: De, Suman, et al.
Publicado: (2019)

Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their Oligomers
por: Limbocker, Ryan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d7jcnc1qb186jifbr04eag6u93